Literature DB >> 10656464

Correspondence re: T. Davis et al., therapy of B-cell lymphoma with anti-CD20 antibodies can result in loss of CD20 antigen expression. Clin. Cancer Res., 5: 611-615, 1999.

A J Grillo-López, L Kunkel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656464

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  2 in total

Review 1.  Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): a case report and review of the literature.

Authors:  Berna Bozkurt Duman; Berksoy Sahin; Melek Ergin; Birol Guvenc
Journal:  Med Oncol       Date:  2011-07-31       Impact factor: 3.064

2.  Radioisotopic localization of (90)Yttrium-ibritumomab tiuxetan in patients with CD20+ non-Hodgkin's lymphoma.

Authors:  S A Jacobs; A M Harrison; S H Swerdlow; K A Foon; N Avril; N Vidnovic; J Joyce; N DeMonaco; K S McCarty
Journal:  Mol Imaging Biol       Date:  2008-09-05       Impact factor: 3.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.